Herpesvirus
DNA vaccine trial initiated for treatment of herpes simplex type 2
Published in AIDS Weekly, November 8th, 2004
This therapeutic vaccine uses PowderMed's proprietary particle mediated epidermal delivery (PMED) technology to deliver a DNA plasmid coding for four HSV2 antigens.
The HSV2 trial, being carried out at The Centre for Clinical Studies in Houston, Texas is being conducted in 36 otherwise healthy individuals with recurrent genital herpes caused by HSV2. In addition to assessing the safety and tolerability of the vaccine, this study will also assess the immune response of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-11-08)
More Articles from AIDS Weekly
- HIV/AIDS Diagnostics
Cobas Amplicor HIV Monitor 1.5 test modified to measure proviral DNA in PBMCs - HIV/AIDS Drug Resistance
Primary drug resistance persists in recently HIV-1 infected adults - HIV/AIDS Therapy
Imperatorin inhibits HIV-1 replication through Sp1-dependent pathway - Obstetrics
Co-infection with HIV and malaria in pregnant women remains a challenge - AIDS/HIV Epidemiology
Temporal trends in HIV-1 epidemic in Russia reported - AIDS/HIV Vaccine
HDAC inhibitors reactivate HIV-1 expression in cellular reservoirs - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
